ALMS
NASDAQ · Pharmaceuticals
Alumis Inc
$7.90
+0.13 (+1.67%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+90.36%
YTD
-11.78%
Open$7.82
Previous Close$7.77
Day High$7.92
Day Low$7.56
52W High$31.35
52W Low$3.76
Volume—
Avg Volume4.35M
Market Cap1.04B
P/E Ratio—
EPS$-3.81
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$19.51
Below
SMA 200
$8.26
Below
RSI (14)
60.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+210.3% upside
Current
$7.90
$7.90
Target
$24.51
$24.51
$15.34
$24.51 avg
$36.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 37.75M | 878.33M | 917.39M |
| Net Income | -382,009,715 | 120.27M | 166.79M |
| Profit Margin | -1,011.8% | 13.7% | 18.2% |
| EBITDA | -411,966,026 | 272.46M | 241.94M |
| Free Cash Flow | — | 126.96M | 147.40M |
| Rev Growth | — | +6.0% | +16.1% |
| Debt/Equity | — | 0.25 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |